Published in Women's Health Weekly, July 6th, 2000
"Central mechanisms related to referred muscle pain and temporal summation of muscular nociceptive activity are facilitated in fibromyalgia syndrome (FMS) patients. The present study assessed the effects of an NMDA-antagonist (ketamine) on these central mechanisms," explained T. Gravennielsen and colleagues at the University of Aalborg in Denmark ("Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients," Pain, 2000;85(3):483-491).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly